Schisandrin C enhances type I IFN response activation to reduce tumor growth and sensitize chemotherapy through antitumor immunity

• Main Authors: Huijie Yang (Author), Xiaoyan Zhan (Author), Jia Zhao (Author), Wei Shi (Author), Tingting Liu (Author), Ziying Wei (Author), Hui Li (Author), Xiaorong Hou (Author), Wenqing Mu (Author), Yuanyuan Chen (Author), Congyang Zheng (Author), Zhongxia Wang (Author), Shengli Wei (Author), Xiaohe Xiao (Author), Zhaofang Bai (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

With the advancing comprehension of immunology, an increasing number of immunotherapies are being explored and implemented in the field of cancer treatment. The cGAS-STING pathway, a crucial element of the innate immune response, has been identified as pivotal in cancer immunotherapy. We evaluated t...